Clinical Trials in Dallas

Showing 5321-5340 of 17,468 trials

A Study to Assess the Effect of Povorcitinib on Digoxin, Rosuvastatin, and Metformin Pharmacokinetics and the Effect of Probenecid on Povorcitinib Pharmacokinetics When Administered Orally to Healthy Adult Participants

NCT06416800

The purpose of this study is to Assess the Effect of Povorcitinib on Digoxin, Rosuvastatin, and Metformin Pharmacokinetics and the Effect of Probenecid on Povorcitinib Pharmacokinetics When Administered Orally to Healthy Adult Participants.

Healthy Participants

Incyte Corporation71 participantsStarted Jun 2024

Dallas, Texas, United States

COMPLETEDNA< 1 mile

Framing Eighteen Coils in Cerebral Aneurysms Trial

NCT01655784

This trial is being conducted in order to compare angiographic outcomes in patients receiving 0.014-0.0155" platinum framing and filling coils (larger diameter coils) versus those treated solely with coils less than 0.014" (with a standard diameter). Hypothesis: Angiographic occlusion at follow-up imaging will be more frequent in patients receiving 0.014-0.0155" platinum coils during embolization compared to those receiving smaller-diameter coils.

Cerebral Aneurysm

Vanderbilt University Medical Center651 participantsStarted Dec 2012

Fresno, California, United States • Englewood, Colorado, United States • Englewood, Colorado, United States +21 more locations

A Study to Assess the Effect of Povorcitinib on Digoxin, Rosuvastatin, and Metformin Pharmacokinetics and the Effect of Probenecid on Povorcitinib Pharmacokinetics When Administered Orally to Healthy Adult Participants

Framing Eighteen Coils in Cerebral Aneurysms Trial

Find Trials by Condition in Dallas

A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-Traumatic Stress Disorder (PTSD)

Comparative Effectiveness of Operative Versus Non-Operative Treatments for Rotator Cuff Tears

A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participants With PTSD

Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib

Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).

A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies

A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006)

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Different Doses of Naronapride Vs. Placebo in Gastroparesis

This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects with Any Progressive Locally Advanced or Metastatic Solid Tumors

Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements

Safety and Immunogenicity of CodaVax-RSV in Seropositive and Seronegative Children

Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy

Open-Label Study of Setmelanotide in Hypothalamic Obesity

Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

A Food Additive Removal Diet for Pediatric Eosinophilic Esophagitis

Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer